NewAmsterdam Pharma Company
NAMS
#3911
Rank
โ‚น334.58 B
Marketcap
โ‚น2,862
Share price
-2.98%
Change (1 day)
40.27%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -โ‚น19.34 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are โ‚น22.56 Million. In 2025 the company made an earning of -โ‚น21.8 Billion, an increase over its 2024 earnings that were of -โ‚น23.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น19.34 Billion-11.26%
2025 -โ‚น21.8 Billion-7.81%
2024 -โ‚น23.64 Billion38.38%
2023 -โ‚น17.09 Billion